It can be concluded that simultaneous attack of BET and FGFR1 proteins may inhibit the mechanisms of intrinsic resistance and have a beneficial effect on inhibiting GBM cell proliferation in clinical settings [267]. This evidence concerns the gene DNER and glioblastoma.